medRxivGenetic & Genomic MedicinePreprint
A portable molecular laboratory for rapid genotyping in the field: application to sickle cell disease
Fabienne GrunderiD, Anne-Flore HämmerliiD, Claude Isofa Nkanga BokembyaiD, Stéphen Hennart, Muriel HelmersiD, Naomi Azur PorretiD, Bertrand Graz, Cécile Choudja Ouabo, Hugues AbrieliD
Abstract
BackgroundSickle cell disease (SCD) is the most common recessive genetic disorder, caused by pathogenic variants of the HBB gene. SCD is associated with a range of clinical manifestations, including vaso-occlusive crises, infections, and severe anaemia, which contribute to increased morbidity and mortality. The frequency of pathogenic alleles is high in Sub-Saharan African countries, with heterozygous carriers reaching up to 25% of the population. Several methods can be employed for molecular diagnostics, with HBB gene sequencing being the most precise. However, access to DNA analyses and sequencing in Low- and Middle-Income Countries (LMICs), where SCD prevalence is high, is limited. Understanding genetic profiles is crucial at both individual and population levels, as it can guide public health strategies and facilitate accurate genetic counselling. AimThis feasibility study aimed to demonstrate that a portable medical genetic laboratory (in suitcases) can be used to genotype individuals for the HBB A, S, and C alleles and their combinations within a few hours outside of a laboratory setting. Methods and resultsWe established a portable medical genetics laboratory capable of DNA extraction and isothermal DNA amplification using a commercially available kit for the A, S, and C alleles of the HBB gene. During one single study day, this portable lab was set up in a room where the Swiss Association of Patients with SCD was holding its annual meeting. We analysed the samples of 27 participants who were aware of their A, S, or C status. We collected buccal swabs and dried blood samples for genotyping. Genotype results for all participants were obtained within five hours after sample collection. In four cases, we observed discrepancies between the buccal swab and blood genotypes; three were resolved upon repeat testing, and one reflected donor chimerism following hematopoietic stem-cell transplantation. ConclusionsThis study demonstrates the feasibility and efficiency of using a portable medical genetics laboratory for rapid genotyping of HBB SCD alleles in community settings.This approach can improve access to molecular diagnostics in resource-limited environments. Such tools have the potential to significantly enhance local capabilities for genetic screening, counselling, and public health planning in regions heavily affected by SCD.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Smartphone-based Sickle Cell Disease Detection and Monitoring for Point-of-Care Settings
- Prenatal diagnosis of sickle cell disease by amniocentesis using FTA technology in a context of precariousness in sub-Saharan Africa: Challenges and perspectives
Nelly Ciombo Kamuanya, Vicky Bolamba Lokomba, … Tite Minga Mikobi·medRxiv·Mar 24, 2026
- Sickle Cell Disease Demographics and Clinical Epidemiology in Gambian Urban and Rural Cohorts Retrospective Analysis
Mustapha Dibbasey, Kevin Kum Esoh, … Alfred Amambua‐Ngwa·medRxiv·Jul 7, 2026
- The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria
Oyesola Oyewole Ojewunmi, Titilope Adenike Adeyemo, … Stephan Menzel·Human Molecular GeneticsPeer-reviewed·Jan 18, 2024
- Use of an automated pyrosequencing technique for confirmation of Sickle Cell Disease
CC Martino, Cecília Salete Alencar, … for the International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III)·PLoS ONEPeer-reviewed·Dec 12, 2019
- Scalable noninvasive amplicon-based precision sequencing (SNAPseq) for genetic diagnosis and screening of β-thalassemia and sickle cell disease using a next-generation sequencing platform
Pragya Gupta, Arvinden VR, … Sivaprakash Ramalingam·Frontiers in Molecular BiosciencesPeer-reviewed·Dec 13, 2023